PDEX - NASDAQ

Pro-Dex, Inc.

PDEX·NASDAQ

$66.88

-1.2%

HealthcareMedical - Instruments & Supplies

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$213.52M

EPS2.7300

P/E Ratio24.50

Earnings Date07/08/2026

pdex

Long Term Debt

Last Annual Value

9.25M

3-Year CAGR

-3%

5-Year CAGR

23%

10-Year CAGR

63%

Adjust for Inflation

Pro-Dex, Inc. Competitors Analysis of Long Term Debt

PDEX · NASDAQ

Company	Long Term Debt	CAGR 3Y	CAGR 5Y	CAGR 10Y
Pro-Dex, Inc. NASDAQ:PDEX	9.25M	1.2%	-2.0%	69.9%
Assertio Holdings, Inc. NASDAQ:ASRT	39.12M	0.8%	-8.6%	-25.3%
Vivani Medical, Inc. NASDAQ:VANI	17.06M	N/A	N/A	N/A
Fortress Biotech, Inc. NASDAQ:FBIO	59.50M	-0.7%	5.0%	8.6%
MindWalk Holdings Corp. NASDAQ:HYFT	0.00	N/A	N/A	N/A
Immunic, Inc. NASDAQ:IMUX	107.00K	N/A	N/A	N/A
Nutriband Inc. NASDAQ:NTRB	58.20K	-10.0%	-10.5%	N/A
Microbot Medical Inc. NASDAQ:MBOT	0.00	N/A	N/A	N/A
Rapid Micro Biosystems, Inc. NASDAQ:RPID	22.58M	N/A	N/A	N/A
Sharps Technology, Inc. NASDAQ:STSS	0.00	N/A	N/A	N/A
Apyx Medical Corporation NASDAQ:APYX	34.85M	1.6%	N/A	28.5%

Pro-Dex, Inc. Fair Value Envelope

PDEX · NASDAQ

Our analysis suggests that PDEX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $66.875, this represents a potential HIDDEN relative to our calculated worth for Pro-Dex, Inc..

HIDDEN

Intrinsic Value

Current Price: $66.875

Related Guides

Blog Categories

Continue your PDEX research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.